The question comes before the answer
Each entry starts with identity: which substance the name describes and which confusions to avoid. It then separates the research question, experiment type and observed result. A list of “benefits” cannot replace that explanation.
The editorial selection includes familiar plant cannabinoids, less-studied acids and homologues, semisynthetic derivatives, endocannabinoids and related medicines. It does not attempt to list every possible molecule or resolve ambiguous commercial identities through assumptions.
Five labels, no recommendation
- Clinical, specific indications: human findings or an assessed medicine exist in a defined setting. This evidence does not automatically extend to other conditions, formulations or routes.
- Early human studies: signals that must be read alongside sample size, comparator, duration and primary outcome.
- Laboratory or animals: findings that help formulate questions. We do not turn them into demonstrated human effects.
- Identity or very sparse data: knowing a name is not the same as knowing its safety or usefulness.
- Mixed evidence: different questions have different levels of support. Each source matters.
Receptor affinity is not a scale of human potency. A secondary statistical result does not replace a trial’s primary outcome. Failure to observe an effect also does not show that it could never occur under any circumstances.
How personal accounts are handled
Experiences appear as brief paraphrases, with the source underneath, its language and an explanation of limitations. A survey collects self-reports; a public comment records an account. Neither verifies product composition or establishes causation on its own.
We do not select only favourable accounts or present an anecdote as typical. Where we cannot find a verifiable account, we say so. We omit consumption instructions, doses, purchase links and details that would turn an entry into a practical use guide.
Sources, dates and editorial responsibility
We prioritise public bodies, regulatory documents and original research. Sources appear near claims and at the end of each entry. Some are in English or other languages; our translations do not claim greater certainty than the original material.
The review date is the documentary consultation date. It does not mean every experiment is recent or that we have performed an exhaustive systematic review. This edition was prepared with AI assistance and reference checking. It has no external clinical review and does not evaluate a commercial product.
Stock images are illustrative and captions make that clear. They are not presented as photographs of trials, participants or identified molecules.
Corrections and new questions
Email info@milnubes.com with the entry, specific claim and a reference that challenges or extends it. Substantive corrections should retain their actual dates; we do not change dates to create an appearance of novelty.